|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | Aptuit, Inc. | Almedica International |
| Expands Aptuit's clinical trial drug supply more... | ||
| Biopharmaceuticals | Bausch & Lomb, Inc. | Shandong China Freda Pharmaceutical Group (China) |
| Aids B&L's expansion in the Chinese market. Acquisition of a 55% interest for $200m cash, representing 18.6x 2004 net earnings. B&L will more... | ||
| Biopharmaceuticals | EpiCept Corporation | Maxim Pharmaceuticals, Inc. (MAXM) |
| Creates a company with a balanced portfolio of pain management and oncology product candidates, making the company less reliant on any one product more... | ||
| Biopharmaceuticals | Express Scripts (ESRX) | Priority HealthCare (PHCC) |
| Cash Deal of $1.3 billion. Positions and strengthens CuraScript as a leader in the specialty pharmaceutical marketplace (fertility, oncology, more... | ||
| Biopharmaceuticals | Genzyme Corporation (GENZ) | Bone Care International, Inc. |
| Strengthens and expands Genzyme's renal business accelerating commercial entry into earlier stages of chronic kidney disease. Cash acquisition more... | ||
| Biopharmaceuticals | GlaxoSmithKline PLC (GSK) | The Marietta, PA vaccine production facility of Wyeth (WYE) |
| The purchase follows GSK's recent acquisition of Corixa. GSK plans to invest $100 million to develop and produce flu vaccines using a new tissue more... | ||
| Biopharmaceuticals | GlaxoSmithKline PLC (GSK) | ID Biomedical Corporation (IDBE) |
| Positions GSK as a leading influenza-vaccine manufacturer, increasing capacity for next generation flu vaccines. Deal value: $1.4 more... | ||
| Biopharmaceuticals | Invitrogen Corporation, (Nasdaq: IVGN) | BioSource International (BIOI) |
| Broadens Invitrogen's collection of protein and primary antibody products which were added through the prior acquisitions of Zymed Labs and more... | ||
| Biopharmaceuticals | Millipore Corporation (MIL) | NovAseptic AB (Sweden) |
| Expands Millipore's product offering to biotech and pharmaceutical sectors. Millipore purchased more than 90% of shares in a $91 million cash more... | ||
| Biopharmaceuticals | Nektar Therapeutics(NKTR) | Aerogen, Inc. (AEGN.PK) |
| Broadens Nektar's capabilities by adding inhaleable liquid drug technology. Deal valued at $32 million. Areogen's revenues are about $8 more... | ||
| Biopharmaceuticals | Novartis AG (NVS) | OTC Brand Portfolio of Bristol-Myers-Squibb Company |
| Novartis acquires the rights to BMS' North American OTC brand portfolio for approximately $660 million ($258 million in sales). Gives Novartis more... | ||
| Biopharmaceuticals | Ortho-McNeil Pharmaceuticals, Inc. (a Johnson & Johnson subsidiary) | Peninsula Pharmaceuticals, Inc. |
| Through the acquisition J&J will own Peninsula’s lead product, doripenem, a broad-spectrum antibiotic. Deal value about $245 million. more... | ||
| Biopharmaceuticals | OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) | Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) |
| Creates a biopharmaceutical company with $600 million in projected 2006 revenue, adding to, and diversifying, OSI's oncology and diabetes more... | ||
| Biopharmaceuticals | Pfizer, Inc. (PFE) | Vicuron Pharmceuticals, Inc. (MICU) |
| Gives Pfizer two new product candidates currently under review at the FDA: anidulafungin for fungal infections and dalbavancin for Gram-positive more... | ||
| Biopharmaceuticals | PharmaDerm Altana Inc. | the prescription dermatology business of GlaxoSmithKline Corporation (GSK). |
| Broadens PharmaDerm's current portfolio and enhances its sales and marketing effort with an expanded more... | ||
| Biopharmaceuticals | RoundTable Healthcare Partners | CorePharma, LLC |
| Provides RoundTable with a new platform investment in generic pharmaceuticals and accelerates CorePharma's growth. RoundTable acquired a more... | ||
| Biopharmaceuticals | Solvay Pharmaceuticals | Fournier Pharma (France) |
| The acquisition boosts Solvay’s cardiovascular pharmaceuticals and accelerates their overall pharmaceutical business, by adding a strong product more... | ||
| Biopharmaceuticals | TEVA Pharmaceutical Industries Ltd (Israel) | IVAX Corporation |
| Creates largest generic drug manufacturer and adds branded products (for cancer, asthma and multiple sclerosis), as well as generics an deeper drug more... | ||
| Data Management/ Healthcare IT | Creative Computer Applications, Inc. (AMEX:CAP) | StorCOMM, Inc. |
| As per this stock merger agreement, CCA can offer integrated clinical and diagnostic applications to a wider customer base (more than 700 existing more... | ||
| Data Management/ Healthcare IT | Elsevier Science B.V. (Netherlands) | MC Strategies, Inc. |
| Expands Elsevier's offerings in online continuing education and more... | ||
| Data Management/ Healthcare IT | IMS Health, Inc. (RX) | Pharmetrics, Inc. |
| Provides enhanced understanding of how medical and pharmaceutical interventions combine to affect more... | ||
| Data Management/ Healthcare IT | McKesson Corporation | Medcon Ltd. |
| McKesson adds cardiac diagnostic digital image management and archiving, procedural reporting and workflow management to its data management more... | ||
| Data Management/ Healthcare IT | Phase Forward (PFWD) | Lincoln Technologies |
| In this all-cash Deal valued at $11 million (plus up to an additional $6 million in milestone payments), Phase Forward adds regulatory expertise and more... | ||
| Data Management/ Healthcare IT | Proxima, Inc. | Daou Systems, Inc. (OTCBB:DAOU) |
| Fortifies Proxicom's IT offerings. Deal value about $21 more... | ||
| Data Management/ Healthcare IT | VNU (the Netherlands) | IMS Health |
| Results in a company providing market intelligence to three major industries: consumer packaged goods, healthcare, and media and entertainment. The more... | ||
| Data Management/ Healthcare IT | Wolters Kluwer NV | The pharmaceutical information management business of NDC Health Corp. |
| Strengthens Wolter Kluwer's position in the growing pharmaceutical, biotech and medical device markets by expanding its business intelligence more... | ||
| Dental | Church & Dwight Company, Inc. (CHD) | SpinBrush(TM) power toothbrush business of the Proctor & Gamble Company (PG) |
| Strengthens C&D's oral care business and allows P&G to divest the business as part of its antitrust negotiations concernng its pending of more... | ||
| Dental | Lifecore Biomedical, Inc. (LCBM) | Bardo-Biotech SAS (France) |
| Positions the Lifecore brand in key European markets, driving continued penetration and complementing r subsidiaries in Germany, Italy and more... | ||
| Dental | Sirona Dental Systems (Germany) | Schick Technologies, Inc. (SCHK.OB) |
| Broadens Sirona's reach in the market, enhancing its global presence and product offering. The Deal is valued at $1.9 billion. The combined more... | ||
| Diagnostics | Caliper Life Sciences, Inc. (CALP) | NovaScreen Biociences |
| Leverages combined expertise and technologies in the growing screening and profiling market. Deal value $22 million in stock and cash with an more... | ||
| Diagnostics | Clinical Data, Inc. (CLDA) | Icoria, Inc. (ICOR.OB) |
| The all-stock Deal valued at $12.5 million strengthens CD's position in targeted diagnostics and theranostics and brings metabolomics and more... | ||
| Diagnostics | Inverness Medical Innovations, Inc. (AMEX: IMA) | Thermo BioStar |
| Provides Inerness with complementary product lines, and a direct sales force of 55 people to market directly to doctors' offices and hospitals. more... | ||
| Diagnostics | Life Therapeutics, Ltd. (LFE.AX) | Pyramid Biological |
| The acquisition increases Life's plasma collection capacity and increases its share of plasma markets. Consists of $13 million plus assumption more... | ||
| Diagnostics | Olympus Corporation | Advalytix AG (Germany). |
| Positions Olympus at forefront of leading edge diagnostics and life science more... | ||
| Diagnostics | Philips Medical Systems | Stentor, Inc. |
| Strengthens Philips' position in the Healthcare IT market by offering an integrated portfolio, adding PACS. Deal valued at $280 million in cash. more... | ||
| Diagnostics | Qiagen N.V. (Netherlands) | Assets of LumiCyte, Inc. |
| Creates an expanded proprietary portfolio for QIAGEN in sample preparation of proteins and peptides. Deal value of $3 million with additional more... | ||
| Diagnostics | Qiagen N.V. (Netherlands) | SuNyx GmbH (Germany) |
| Positions QIAGEN as leading provider for standardized, on-chip sample preparation in the rapidly growing field of MALDI and LC-MALDI Mass more... | ||
| Diagnostics | Quest Diagnostics Incorporated (DGX) | LabOne, Inc. (LABS) |
| Strengthens Quest's existing business and adds several new lines -- health screening and risk assessment services to the life insurance industry. more... | ||
| Distribution | McKesson Corporation | D & K Healthcare Resources |
| Gives McKesson more clout against rivals Cardinal and Amerisource, particularly in the midwest and south. D&K's 2004 revenues were about $2.5 more... | ||
| Distribution | Omnicare Inc. (OCR) | ExcelleRx |
| Expands Omnicare’s hospice services and provides a platform for growth. Total purchase price of $269 million in cash. Total revenues for more... | ||
| Medical Devices | Accellent, Inc. | Campbell Engineering |
| Strengthens Accellent's engineering and production capabilities, in prepartion for its impending sale to more... | ||
| Medical Devices | Alphatec Spine, Inc. | Cortek, Inc. |
| Provides Alphtatec, owned by Healthpoint Capital, with a wider range of spinal fusion products. Allographs are recognized for accelerating lumbar more... | ||
| Medical Devices | American Medical Systems, Inc. (AMMD) | Ovion, Inc. |
| Broadens AMS' gynecological product base with office-based technology. FDA approval is anticipated by late 2008. Deal value of $10 million cash more... | ||
| Medical Devices | Arizant, Inc. | Actamed Ltd. |
| Actamed is Arizant's U.K. distributor. Purchase of 75% of the equity not already owned by Arizant. Terms not more... | ||
| Medical Devices | ArthroCare Corp. (Nasdaq:ARTC) | Applied Therapeutics, Inc. |
| Arthrocare distributed Applied's wound care products in select areas, now adding the $5 million lines to its own. $10 million Deal more... | ||
| Medical Devices | Best Medical International, Inc. | Vascular Brachytherapy (VBT) business of Novoste Corporation (NASDAQ:NOVT) |
| As per this asset purchase agreement, Best re-enters the VBT market with the last remaining independent VBT on the market. (Cordis/J&J and more... | ||
| Medical Devices | Boston Scientific Corporation (BSX) | Biophan Technologies |
| Grants Boston Scientific licensing covering patents relating to MRI safety and image compatible technologies, thereby enhancing Boston's more... | ||
| Medical Devices | Cantel Medical Corporation (CNM) | Crosstex International, Inc. |
| Extends Cantel's infection control business into the dental arena, for a purchase price of $74.2 million in cash and stock. Additional $12.0 more... | ||
| Medical Devices | Cardiac Science, Inc. (DFIB) | Quinton Cardiology Systems, Inc. (QUIN) |
| The merged companies combines many cardiovascular products, including holter monitors, stress test systems, cardiac rehab telemetry systems, and more... | ||
| Medical Devices | Complete Care Medical, Inc. (CCMI.PK) nc. (CCMI.PK) | International Medical Devices, Inc. |
| Secures supply of diabetes devices for CCM and adds depth to its direct to consumer marketing more... | ||
| Medical Devices | Cordis Corporation | LuMend, Inc. |
| Provides Cordis with devices to treat chronic total occlusions, a peripheral vascular problem. Acquired product lines include special catheters to more... | ||
| Medical Devices | dj Orthopedics, Inc. (DJO) | Orthopedics Soft Goods business of Encore Medical Corporation |
| Strengthens DJ's domestic rehabilitation business and adds substance to the soft goods franchise, adds complementary products (i.e. safety more... | ||
| Medical Devices | Hologic, Inc.(HOLX) | The mamography intellectual property of Fisher Imaging Corporation |
| The acquisition completed on 9/29/05 provides Hologic with the SenoScan® digital mammography and MammoTest® stereotactic breast biopsy more... | ||
| Medical Devices | Hospira, Inc. | Physiometrix, Inc. |
| Strengthens Hospira's position in patient safety during surgical and diagnostic procedures, providing sedation monitoring products. Deal valued more... | ||
| Medical Devices | Huntleigh Technology plc (U.K.) | The cardiovascular and obstetric analysis and monitoring businesses of VIASYS Healthcare Inc. |
| Adds the Sonicaid™ and Medilog™ diagnostic products and sales through Huntleigh's existing distribution network. Deal value - $7.1m. more... | ||
| Medical Devices | Integra Life Sciences Holding Corporation (IART) | Eunoe, Inc. |
| Extends Integra's technology base relevant to the management of conditions that require regulation of Cerebrospinal Fluid (CSF) flow within the more... | ||
| Medical Devices | Medtronic, Inc. (MDT) | Image-Guided Neurologics |
| Strengthens Medtronic's position in deep brain stimulation, with products that simplify procedures for implanting its Activa Therapy more... | ||
| Medical Devices | MicroMed Technology, Inc. | Salmon Express |
| Enables Micromed, renamed MicroMed Cardiovascular, Inc., go public and better promote its VAD more... | ||
| Medical Devices | Micrus Endovascular Corporation | VascularFX |
| Expands Micrus's neuro endovascular product line to include steerable catheters and guidewires for treatment of brain aneurisms. Deal price $4 more... | ||
| Medical Devices | Micrus Endovascular Corporation (MEND) | Neurologic UK Limited Endovascular products in the United Kingdom |
| Enhances Micrus' market penetration in the UK. Initial cash payment of $4.7 million and multi-year revenue-based earn out. For fiscal year 2005, more... | ||
| Medical Devices | Nexa Orthopedics | Pioneer Surgical, Inc. |
| Acquisition of the trademarked StayFuse product line, a novel product used to fuse the interphalangel of the foot and hand. Expands Nexa's more... | ||
| Medical Devices | NuVasive, Inc.(NASDAQ:NUVA) | Cervical replacement Technology from Pearsalls Limited |
| Offers NuVasive a market-first cervical nucleus-like device designed to preserve motion in the cervical region of the spine and fill the gap between more... | ||
| Medical Devices | Ossur Ltd. (Iceland) | Royce Medical Holding Inc. |
| Adds a non-overlapping O&P product line, increasing Ossur's US footprint against Otto Bock. Adds a major a field sales force and more... | ||
| Medical Devices | Recom Managed Systems, Inc. (RSY) | OTC cardiac event recorder line of TZ Medical, Inc. |
| The agreements involve the acquisition of significant existing products and devices that will immediately enhance Recom's market share while more... | ||
| Medical Devices | SanuWave, Inc. | The orthopedic electrocorporeal shockwave lithotripsy business of HealthTronics (HTRN) |
| Expands SanuWave's orthopedic technology base and positions it for growth in non-urological shockwave treatment. Allows HealthTonics to focus on more... | ||
| Medical Devices | Soteira, Inc. | Competitive Technologies, Inc. (CTT) |
| Grants Soteira exclusive license to manufacture and sell CTT nanotechnology bone material for applications related to the human spine. Enhances more... | ||
| Medical Devices | Tyco International Ltd. | Floreane Medical Implants SA (France) |
| Expands Tyco's surgical product portfolio, with a complementary range of products, and allows Tyco to capitalize on its global sales force and more... | ||
| Medical Devices | West Pharmaceutical Services, Inc. (WST) | Medimop Medical Projects, Ltd (Israel) |
| Enhances West's position in the growing drug reconstitution and injectable markets. West purchased 90% of Medimop's shares for $36 million more... | ||
| Medical Devices | WorldHeart Corporation | MedQuest Products, Inc. |
| Adds an advanced rotary pump to WorldHeart’s VAD more... | ||
| Medical Devices | Zimmer Holdings, Inc. | Revivicor, Inc. |
| Zimmer obtained the worldwide exclusive for genetically engineered xenogeneic technology for tissue regeneration. Positions Zimmer as a leader in the more... | ||
| Medical Services | Alliance Medical Corporation | Vanguard Medical Concepts |
| Consolidates two competitors, lowers costs and increases operating leverage and customer service more... | ||
| Medical Services | American Laser Centers | Advanced Laser Clinics, Inc. |
| Creates a national provider with over 100 clinics in 31 states and solidifies the company's position as a significant hair removal and skin more... | ||
| Medical Services | Apria Healthcare Group, Inc. | VitalAire Homecare (US HME operations of Air Liquide, Paris, France) |
| Air Liquide is leaving the U.S. market to focus on its European activities where it has established solid positions. Terms not disclosed but more... | ||
| Medical Services | Aptuit, Inc. | Preclinical Services, Pharmaceutical Services, and Clinical Trial Supplies business units of Quintiles Transnational Corporation |
| Grows Aptuit's pharmaceutical services business while the commercial agreement and cash enables Quintiles to grow internally and meet demands for more... | ||
| Medical Services | Berkshire Partners LLC | National Vision, Inc. (NVI) |
| Deal value - $43 million for 85.1% of the outstanding shares. Subject to the completion of NVI's acquisition of Consolidated Vision Group, in more... | ||
| Medical Services | Careguide, Inc. | Patient Infosystems, Inc.(PATY) |
| The merger (into a pulbic company) combines leading care and disease management companies supporting the public and private sectors as well as more... | ||
| Medical Services | HealthTronics Surgicial Services, Inc. (HTRN) | Cascade Urological Services, LLC; Cascade Laser Services, LLC |
| Healthtronics acquired a 33% interest (terms undisclosed). Broadens Healthtronics' scope of urology services. In 2004, Cascade performed over more... | ||
| Medical Services | North American Senior Care | Beverly Enterprises, Inc. |
| In this $1.9 billion dollar deal, NASC has outbid other suitors in expanding its long-term care operations. The same group of investors behind NASC, more... | ||
| Medical Services | Omnicare Inc. (OCR) | NeighborCare, Inc. |
| Enhances Omnicare's position as a provider of pharmacy services for the elderly. The combined company will have a nationwide network of more... | ||
| Medical Services | Omnicare Inc. (OCR) | RxCrossroads, L.L.C. |
| Expands Omnicare's position as a provider of custom product solutions to pharmaceutical and biotechnology companies. Deal value: $235 million. more... | ||
| Medical Services | PainCare Holdings Inc. | The Center for Pain Management ASC LLC |
| The $15 million Deal in cash and restricted shares provides PainCare with enhanced market penetration. The acqusition is forecasted to contribute more... | ||
| Medical Services | PolyMedica Corporation (PLMD) | National Diabetic Pharmacies |
| Allows PolyMedica significant entry into the commercial market. Deal valued at $55 more... | ||
| Medical Services | Renal America, Inc. | 70 dialysis centers being divested by Davita and Gambro |
| Grows Renal America to the fourth largest outpatient dialysis providers in the U.S. Backed by Welsh, Carson, Anderson & Stow, the deal size is more... | ||
| Medical Services | Ventiv Health, Inc. (VTIV) | Pharmaceutical Resource Solutions, LLC |
| Strengthens Ventiv's commercial services division among smaller sizes companies, a key audience for outsourced services. The Deal is valued at more... | ||
| Medical Services | Vision Acquisition Corporation | National Vision, Inc. (NVI) |
| The merger will combine NVI and CVG into the fourth largest retail optical chain in the United States. The cash tender offer by Vision Acquisition more... | ||
| Medical Services | WellPoint, Inc. (WLP) | WellChoice, Inc. |
| Expands WP into New York State, giving it a major foothold in the Northeast, bringing in 5 million customers. Combined company will serve 33 million more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||